Engineering B cells with customized therapeutic responses using a synthetic circuit.

Area of Science:

• Synthetic immunology
• Genetic engineering
• Cellular engineering

Background:

• Immune cells, particularly B cells, are ideal for synthetic biology due to their patrol, interaction, proliferation, and memory capabilities.
• Genetic engineering advancements enable the development of novel synthetic circuits for precise control over cellular functions.

Purpose of the Study:

• To implement a synthetic circuit in B cells for antigen-induced, temporally and spatially restricted expression of therapeutic molecules.
• To enhance endogenous B cell recognition and effector functions through a programmable synthetic system.

Main Methods:

• Development of a synthetic circuit comprising a sensor (membrane-anchored B cell receptor), a transducer (antigen-activated minimal promoter), and effector molecules.
• Isolation of a 734-bp NR4A1 promoter fragment, activated reversibly by the sensor signaling cascade.
• Demonstration of antigen-specific circuit activation and effector expression upon antigen recognition.

Main Results:

• Successful implementation of a synthetic circuit in B cells.
• Demonstrated antigen-specific activation of the NR4A1 promoter and subsequent effector molecule expression.
• Achieved fully reversible circuit activation in response to specific antigens.

Conclusions:

• Novel synthetic circuits in B cells offer programmable control over therapeutic molecule expression.
• This technology enhances B cell functionality and holds significant potential for treating diverse pathologies.
• Adaptable sensor and effector components allow for tailored applications in various disease contexts.